Showing 401-410 of 8879 results for "".
Agminated Pyogenic Granuloma: De Novo Presentations and Review of the Literature
https://practicaldermatology.com/youngmd-connect/resident-resource-center/agminated-pyogenic-granuloma/23221/Look to the EAST: Shared Decision Making in the Era of New Therapies
https://practicaldermatology.com/topics/atopic-dermatitis/look-to-the-east-shared-decision-making-in-the-era-of-new-therapies/23372/Assessing Efficacy, Accessibility, Safety, and Tolerability is the key to a meaningful dialogue with patients.Updates on Nitric Oxide As a Topical Anti-infective
https://practicaldermatology.com/topics/practice-management/updates-on-nitric-oxide-as-a-topical-anti-infective/21071/NO continues to show promise as a safe and effective topical treatment candidate for acne and other infectious dermatoses.Therapeutics Update: New products and pharmacologic developments
https://practicaldermatology.com/columns/new-products/therapeutics-update-new-products-and-pharmacologic-developments/20324/Case Report: Henoch-Schönlein Purpura in an Adult; Resident Salary Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-henoch-schnlein-purpura-in-an-adult-resident-salary-report/20909/Mechanism of Action Matters: A Review of New and Emerging Biologics
https://practicaldermatology.com/issues/supplements/mechanism-of-action-matters-a-review-of-new-and-emerging-biologics/23178/The Gender Gap in Dermatology: Where Are We Now?
https://practicaldermatology.com/topics/general-topics/the-gender-gap-in-dermatology-where-are-we-now/20820/Despite advances, women are still not equally represented in academic dermatology or dermatology leadership.A.G.E. Interrupter Advanced: Newest Innovative Anti-Aging Cream
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/age-interrupter-advanced-newest-innovative-anti-aging-cream/23930/The Placebo and Nocebo Effects in Dermatology
https://practicaldermatology.com/columns/clinical-focus-1/the-placebo-and-nocebo-effects-in-dermatology/23559/Increasing evidence suggests that these effects—though not fully understood—may be harnessed for patient care.Cutaneous T-Cell Lymphoma: Mogamulizumab as a Novel Treatment for Refractory Mycosis Fungoides and Sezary Syndrome
https://practicaldermatology.com/youngmd-connect/resident-resource-center/Cutaneous-T-Cell-Lymphoma-Mogamulizumab-as-a-Novel-Treatment-for-Refractory-Mycosis-Fungoides-and-Sezary-Syndrome/23409/An overview of the diagnosis and prognosis of CTCL.